According to these findings, baseline serum NGAL might serve as a predictor of the development of CI-AKI and cardiac and cerebrovascular outcomes in patients with CAD undergoing PCI before the administration of contrast medium. This evidence concerns the gene LCN2 and acute kidney injury.